Iveric Bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatments for retinal diseases with significant unmet medical needs.
Employees: 51-200
Founded date: 2007
Investors 2
| Date | Name | Website |
| 23.03.2023 | Avoro Capi... | avorocapit... |
| 09.06.2023 | Hercules C... | htgc.com |
Mentions in press and media 3
| Date | Title | Description | Source |
| 03.03.2021 | Iveric Bio Reports Fourth Quarter and Year End 2020 Operatio... | NEW YORK--(BUSINESS WIRE)--Mar 3, 2021-- IVERIC bio, Inc. (Nasdaq: ISEE) today announced financial a... | oaoa.com/n... |
| - | Iveric Bio Reports Inducement Grants Under Nasdaq Listing Ru... | NEW YORK--(BUSINESS WIRE)--Mar 16, 2021-- IVERIC bio, Inc. (NASDAQ: ISEE) today reported that on Mar... | oaoa.com/n... |
| - | Iveric Bio to Report Fourth Quarter and Full Year 2020 Finan... | NEW YORK--(BUSINESS WIRE)--Feb 24, 2021-- IVERIC bio, Inc. (Nasdaq: ISEE) today announced that it wi... | oaoa.com/n... |